Corcept Therapeutics Incorporated · NASDAQ:CORT
Lyon Joseph Douglas sold 10,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded Sep 14, 2026 · Filed Sep 16, 2026
On Sep 14, 2026, Lyon Joseph Douglas (See Remarks) sold 10,000 Corcept Therapeutics Incorporated shares at an average US$113.50 for US$1.13M under a trading plan, leaving 5,683 shares. Filed Sep 16, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$113.50 average (US$113.32 to US$114.12)
- Value
- US$1.13M
- Holding after
- 5,683 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | Option exercise | 2,596 | US$11.35 | 8,279 | Direct |
| Sep 14, 2026 | Common Stock | Option exercise | 7,404 | US$13.56 | 15,683 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 7,812 | US$113.32 | 7,871 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 2,188 | US$114.12 | 5,683 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Lyon Joseph Douglas
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Sep 3, 2026
- Form 4 · Lyon Joseph Douglas · Aug 5, 2026
- Form 4 · Lyon Joseph Douglas · Jun 3, 2026
- Form 4 · Lyon Joseph Douglas · May 29, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026
- Form 4 · Robb Gary Charles · Sep 18, 2026